See the DrugPatentWatch profile for Ubrelvy
Ubrelvy's tier level on insurance formularies can vary significantly by plan, impacting out-of-pocket costs for patients. Generally, it is often placed on higher tiers due to its status as a newer, branded medication for migraine treatment [1].
What tier is Ubrelvy typically on?
Ubrelvy (ubrogepant) is frequently found on preferred or non-preferred specialty or high-cost drug tiers, depending on the specific insurance provider and formulary design [1]. This often means a higher copay or coinsurance compared to lower-tier medications.
How do Ubrelvy tier levels affect patient costs?
When Ubrelvy is placed on a higher tier, patients can expect to pay more out-of-pocket. This could be a fixed dollar amount copay or a percentage of the drug's cost (coinsurance). The exact amount is determined by the patient's individual insurance plan. Manufacturers often provide savings cards or assistance programs to help offset these costs for eligible patients [1].
What is Ubrelvy used for?
Ubrelvy is an oral medication approved for the acute treatment of migraine with or without aura in adults [1]. It works by targeting calcitonin gene-related peptide (CGRP) receptors, which are believed to play a role in migraine pain [2].
How does Ubrelvy compare to other migraine treatments?
Ubrelvy is a CGRP receptor antagonist, offering a different mechanism of action compared to older acute migraine treatments like triptans or NSAIDs [2]. While triptans often constrict blood vessels, Ubrelvy directly targets the CGRP pathway. Its effectiveness and side effect profile can differ for individual patients, leading to varied experiences and preferences.
Are there alternatives if Ubrelvy is too expensive?
For individuals facing high costs due to Ubrelvy's tier placement, alternative acute migraine treatments include generic triptans, NSAIDs, or other CGRP antagonists [2]. Discussing treatment options and cost-saving strategies with a healthcare provider is crucial for managing migraine effectively and affordably.